Mentions
Extended reach
Total likes
Video views
AI synopsis
The collection exhibits a strong recognition of the study’s significance, with examples like references to the 25% reduction in cardiovascular events and mortality, and mentions of how the findings challenge prior norms. The tone ranges from supportive to skeptical, using words like 'game changer' and 'misinformation,' which reflect both high engagement and debate about the real-world impact of the research.
Most discussions acknowledge the positive findings of the study, especially regarding the benefits of intensive blood pressure control, despite some skepticism or requests for nuance.
The discussions demonstrate high interest, with many references to detailed results, trial specifics, and debate over clinical implications.
Participants actively engage by citing studies, quoting specific results, and referencing guidelines, indicating a willingness to explore the topic in depth.
This collective conversation indicates that the study’s findings are influential, shaping opinions on blood pressure management and possibly affecting future guidelines.
@Dr_Reyner_Solis No pa. El estudio SPRINT demostró que, si bien hay un beneficio del control tensional estricto, también hay un aumento de eventos adversos. Por ende, la medicina es personalizada, siempre basada en el juicio clínico y en distintas poblaciones. 10.1056/NEJMoa1511939
「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？」 https://t.co/i6Qyw4zztD ↓
7/ Die Änderung der Bluthochdruck-Grenze basiert auf Daten einer grossen randomisierten Studie mit über 9’000 Proband:innen. Die Änderung gab es also wegen neuer, präziserer Evidenz. Es war nicht einfach eine willkürliche Entscheidung. https://t.co/KSchsk0Et2
Claims of efficacy are extremely dubious. The trial ends with only 34 participants out of more than 100. Most well-conducted modern trials to determine efficacy of medical treatments have thousands of participants. See this trial, for example: https://t.co/5DFGr2jW5V
Dr Attiaが血圧が高すぎないことが大事だと言っていたことを先日のFOREVER23でシェアしました。 たまたま「血圧は心配しなくていい」と言うある先生のビデオを見て下のリサーチ結果をシェアするべきだと思いました。NEJMに載った物でとても信頼度が高い物です。 https://t.co/zYkQomJOpK #ライブラン https://t.co/hOPqSbLYeV
T0c: In the
Hypertension, often called primary or idiopathic, has largely unknown causes. This analysis reviews evidence supporting lifestyle modifications and medication strategies, referencing key studies like the SPRINT trial…
This video examines the evidence against aggressive blood pressure lowering in people with type 2 diabetes, highlighting potential risks and questioning the benefits of targeting systolic pressures of 120 mm Hg for…
This study examines whether replacing sugar-sweetened beverages with noncaloric options can lead to long-term weight loss. The meta-analysis found a modest BMI reduction of about 0.31 kg/m², with effects potentially…
This video discusses the 2018 guideline developed by major health organizations, providing evidence-based recommendations for assessing, preventing, and managing high blood cholesterol to reduce cardiovascular risk. It…
Learn results from the SPRINT trial on intensive blood pressure management in less than 2 minutes with new NEJM Quick Take video summary. The study compares systolic blood pressure targets of less than 120 mm Hg versus…
Discover how various lifestyle factors influence blood pressure. This video explores the effects of exercise, sleep quality, and dietary habits. Learn about the potential benefits of taurine supplementation, which has…
Discover the recent updates to hypertension guidelines for 2025, including new diagnostic thresholds and treatment goals. These changes affect how hypertension is diagnosed and managed, especially for patients with…
Your kidneys balance calcium, phosphorus, and vitamin D with precision. When disrupted by chronic kidney disease, it weakens bones and causes artery calcification. Effective management includes phosphorus binders and…
Every 40 seconds someone in the US suffers a stroke, with risks increasing after age 50. Dr. Edward discusses five common factors that raise stroke risk—high blood pressure, cholesterol, heart disease, diabetes, and…
This video explores the ideal blood pressure levels for your age, highlighting the risks of high blood pressure and silent hypertension. Dr. Andr Wambier discusses three key pressures to monitor and introduces a simple…
Prof. Johannes Mann discusses target blood pressure values for individuals with elevated cardiovascular risk based on the STEP trial presented at the European Society of Cardiology. The conversation interprets results…
This week's podcast covers topics including Inclisiran updates, sodium channel blockers, and analytic flexibility in research. The study on class 1C antiarrhythmics shows they can reduce PVCs and improve heart function…
This week, Dr. John Mandrola discusses the PREVENT score, GLP1 mechanism in cardiovascular disease, statin benefits, and issues with hospitalization endpoints in heart failure trials. Key insights include comparing…
Discover the 6 scientifically-backed steps to remove plaque from your arteries and improve heart health. Exploring benefits of exercise intensity, Mediterranean diet, and stress management, this video offers essential…
This video reviews evidence on blood pressure control in older, frail patients, highlighting the balance between reducing cardiovascular events and potential risks like kidney problems. It emphasizes personalized…
The SPRINT trial examined systolic blood pressure targets less than 120 mm Hg versus less than 140 mm Hg in high-risk individuals without diabetes. Results showed fewer cardiovascular events and deaths with intensive…
Discover the evidence-based strategies for improving heart health and addressing plaque in arteries. This video covers six key steps, including exercise, diet, and stress management, while highlighting the complexities…
Osteoporosis affects many people and often goes unnoticed until severe damage occurs. This video explores effective strategies like resistance training and discusses the role of calcium in maintaining strong bones…
RT @han_francis: @MidwesternDoc This is what you get when you systematically ignore the data you don't like https://t.co/yYAv73LCId
@MidwesternDoc This is what you get when you systematically ignore the data you don't like https://t.co/yYAv73LCId
@hikegami3 https://t.co/Q9jKaPsRUR
RT @manabunoda: SPRINT試験って、一般的にはどっちを指すの？ A Randomized Trial of Intensive versus Standard Blood-Pressure Control https://t.co/8dgvE4Y05u Fi…
SPRINT試験って、一般的にはどっちを指すの？ A Randomized Trial of Intensive versus Standard Blood-Pressure Control https://t.co/8dgvE4Y05u Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/ioWyDsPBUT
@Lunatic__Fringe @JasonBardi @ValerieAnne1970 This is a dumb article that ignores any nuance we understand of cardiac pathophysilogy. There is Clear evidence that cardiac remodeling is halted and or reversed with more intensive BP control. https://t.co/UaF12uaylL https://t.co/vcNmTCD8gJ
SUA PRESSÃO 12x8 Não É Mais Normal? Veja as Novas Diretrizes AGORA! - YouTube https://t.co/RsVdGz5la6
@ducavendish A resposta está nesse artigo https://t.co/EH9xjdHfS0 embora não seja o único, todos são livres para fazerem pesquisas mais amplas e mais confiáveis para mudarem as próximas diretrizes
RT @PetersenKe10295: @VigilantFox https://t.co/aAlmUaLmAY
RT @DoctorMeeple: @LoboEstrategia Léete esto, porfa SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure…
@LoboEstrategia Léete esto, porfa SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. NEJM, 2015;373:2103–16.
https://t.co/BiMuB1FYnX
https://t.co/4QAg5BLyZr
@ScienceGuy2718 @g74076 @ifixhearts @DrAseemMalhotra https://t.co/4pdWAcw9I9 with risks for cardiovascular disease, a goal of 120 is better than a goal of 140
https://t.co/RBTWFachMQ
https://t.co/ztmeskvAs5
Qual a MELHOR PRESSÃO ARTERIAL para SUA IDADE? https://t.co/qsRYekHRov via @YouTube
Qual a MELHOR PRESSÃO ARTERIAL para SUA IDADE? https://t.co/is01wDKtHh via @YouTube
https://t.co/d0hv5BYTT2
Olá! Assista a nosso vídeo novo que acabou de sair
RT @AcidoRinon: @Dr_Reyner_Solis No pa. El estudio SPRINT demostró que, si bien hay un beneficio del control tensional estricto, también ha…
@Dr_Reyner_Solis No pa. El estudio SPRINT demostró que, si bien hay un beneficio del control tensional estricto, también hay un aumento de eventos adversos. Por ende, la medicina es personalizada, siempre basada en el juicio clínico y en distintas poblaciones. 10.1056/NEJMoa1511939
@grok @randoc3 @MidwesternDoc Hmm. You might want to double check Grok. https://t.co/GbLeEpAbwK
11) SPRINT: Showed clear #CV benefit ❗ Included #CKD, excluded #T2D
11) SPRINT: Showed clear #CV benefit ❗ Included #CKD, excluded #T2D
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
RT @takua_scientist: 「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？…
「高血圧の基準は、どんどん下がっているんですよ」 これは事実 「金儲けのためだ！」 これは陰謀論… 単純すぎるのよ。ゆるゆるなのよ。 ↓↓↓実際（の一部）↓↓↓ 2015年 SPRINT試験「血圧120に厳密管理したほうが良くね？」 https://t.co/i6Qyw4zztD ↓
@VigilantFox https://t.co/aAlmUaLmAY
RT @Gumby590: @VigilantFox https://t.co/6sWs2To9aE True many measurements are wrong, but there is plenty of evidence that lowering an actu…
@VigilantFox https://t.co/6sWs2To9aE True many measurements are wrong, but there is plenty of evidence that lowering an actual high blood pressure with meds is associated with fewer CV events, including fatal ones.
@ValerieAnne1970 This was answered in 2015 with a large randomized clinical trial that was funded by the NIH and NOT Big Pharma where lower target BP (120/80) was associated with a reduction in major adverse cardiovascular events. Stop spreading misinformation. https://t.co/zxvfsRPZQf
https://t.co/1XqhcYZiQF
@HumMikael @Nefrogeria2024 @galindozip @AryMartnez16 SPRINT-Trial 10.1056/NEJMoa1511939 https://t.co/I7ltAsaYM3
@Otonbem Fuente raíz? La mía es https://t.co/MJhsWUhVOm
@Otonbem Fuente raíz? La mía es https://t.co/MJhsWUhVOm
RT @notoskarisaak: Concretamente el objetivo <120 disminuyó los eventos CV en un 25% y la mortalidad global en 27%. Así que POR FAVOR dejem…
Concretamente el objetivo <120 disminuyó los eventos CV en un 25% y la mortalidad global en 27%. Así que POR FAVOR dejemos de decir a la gente que con PAS 130 mmHg están bien!!! Os dejo el link al estudio SPRINT, que no me lo estoy inventando https://t.co/MJhsWUhVOm
Concretamente el objetivo <120 disminuyó los eventos CV en un 25% y la mortalidad global en 27%. Así que POR FAVOR dejemos de decir a la gente que con PAS 130 mmHg están bien!!! Os dejo el link al estudio SPRINT, que no me lo estoy inventando https://t.co/MJhsWUhVOm
@svennebananars @JacquiDeevoy1 https://t.co/A6C7aypu79
@ValerieAnne1970 Those lousy scientists testing their hypotheses: https://t.co/ANMN03Vwwf
@PierreKory @MidwesternDoc Explain this: https://t.co/9zLsgHzGwX
Lo dijo el SPRINT en pacientes de alto riesgo, según el estudio, en el 2015. https://t.co/cdC8WSJG7Z
@renecardio4 @AHAMeetings Y el que empezó todo y no se le creyó mucho. https://t.co/cdC8WSJG7Z
RT @SwissHeartDoc: @HeartOTXHeartMD SPRINT trial in the NEJM https://t.co/BJsgLtFOHi
@juneslater17 SPRINT trial in NEJM 2015. Almost 10 years old. https://t.co/BJsgLtFgRK
@HeartOTXHeartMD SPRINT trial in the NEJM https://t.co/BJsgLtFOHi
2/10 What did I miss? Until now studies such as SPRINT (without DM) & ACCORD (with DM), suggested how different populations may benefit differently from intensive BP control. #NephJC SPRINT: https://t.co/isYOAzbIS1 ACCORD: https://t.co/Q3gNS60PxF
Recordando SPRINT
T0j/
T0i/
RT @NephJC: T0j: #NephJC
T0j: #NephJC
RT @NephJC: T0i/
T0i/
RT @JohnTal6: @selberpflegen Empfehlung basiert auf folgender randomisierten Studie: https://t.co/aY76ddyo5x bestätigt übrigens vorherige…
@selberpflegen Empfehlung basiert auf folgender randomisierten Studie: https://t.co/aY76ddyo5x bestätigt übrigens vorherige RCT 120 vs 140 mmHg syst https://t.co/qAuS42Q9xK Metaanalyse https://t.co/b6caN0HiUN Sie haben keine Ahnung gute Frau
@JASN_News @gchertow @StanfordNeph @ManjulaKTamura @NMPajewski @PDrawz @taraichang @UofUMedicine The main observation of the original Sprint study was an approximately 25% reduction in MACE and all-cause mortality in the intensive treatment arm (DOI: 10.1056/NEJMoa1511939).
@dranulala @m_palsania @DrMarthaGulati @PamTaubMD @ErinMichos @robmentz @QuentinYoumans Haven't we known this for like almost 10 years? https://t.co/JraXS07dHa
@TBreitschneider Man muss schon etwas an Verfolgungswahn leiden wenn jegliche wissenschaftliche Erkenntniss sofort in die böse Pharmaecke beschoben wird. Ein niedriger Blutdruck ist nunmal vorteilhaft. Gibt genügend große randomisierte Studien https://t.co/qAuS42Q9xK https://t.co/aY76ddyo5x https://t.co/zWmoeu6s6o
RT @cremieuxrecueil: @EricTopol @TheLancet I don't know what you mean by this being the first trial to target <120 vs <140 mm Hg. ESPRIT st…
@EricTopol @TheLancet I don't know what you mean by this being the first trial to target <120 vs <140 mm Hg. ESPRIT started years after SPRINT had already targeted <120 vs <140 with practically the same result. https://t.co/KrcOVm3YPe The NHLBI's Expert Panel on a Hypertension Treatment Trial https://t.co/YEi8VQwTi0
@EricTopol @TheLancet (for readers not familiar with SPRINT) https://t.co/BlN4Oabk0U
RT @cardiomet_CE: 12c) ... reduces cardiovascular events and mortality in patients with CKD by 25%–30% #VisualGraphic from @Dilushiwijay @N…
12c) ... reduces cardiovascular events and mortality in patients with CKD by 25%–30% #VisualGraphic from @Dilushiwijay @NephJC #Nephpearls
RT @ckd_ce: 12c) ... reduces cardiovascular events and mortality in patients with CKD by 25%–30% #VisualGraphic from @Dilushiwijay @NephJC…
12c) ... reduces cardiovascular events and mortality in patients with CKD by 25%–30% #VisualGraphic from @Dilushiwijay @NephJC #Nephpearls
RT @marko_kovic: 7/ Die Änderung der Bluthochdruck-Grenze basiert auf Daten einer grossen randomisierten Studie mit über 9’000 Proband:inne…
RT @marko_kovic: 7/ Die Änderung der Bluthochdruck-Grenze basiert auf Daten einer grossen randomisierten Studie mit über 9’000 Proband:inne…
7/ Die Änderung der Bluthochdruck-Grenze basiert auf Daten einer grossen randomisierten Studie mit über 9’000 Proband:innen. Die Änderung gab es also wegen neuer, präziserer Evidenz. Es war nicht einfach eine willkürliche Entscheidung. https://t.co/KSchsk0Et2
Be Healthier Than 99% of People - Diet principles https://t.co/L0nySkPIxK
Estudio reciente: https://t.co/brtyP2ckxj Corrobora que el control estricto de la presión arterial en pacientes hipertensos mejora el pronóstico de complicaciones cardio y cerebrovasculares y ademas el riesgo de padecer demencia.
RT @thmonk_pf: 厳格な収縮期血圧(SBP)降下はGlymphatic system障害を抑制 SPRINT試験(https://t.co/e6RLavmmkt)Sub解析(N=382) SBP<120mmHgの群、Ca拮抗剤服用群はSBP<140mmHgの群と…
厳格な収縮期血圧(SBP)降下はGlymphatic system障害を抑制 SPRINT試験(https://t.co/e6RLavmmkt)Sub解析(N=382) SBP<120mmHgの群、Ca拮抗剤服用群はSBP<140mmHgの群と比較し4年後のMRIで血管周囲腔体積が有意に減少 Open Access #blood_pressur #glymphatics #papers https://t.co/EZHlEp3dsQ
@ambilinski SPRINT trial was 9,361 patients The intervention was stopped early after a median follow-up of 3.26 years. All-cause mortality was significantly lower in the intensive-blood pressure treatment group (hazard ratio, 0.73; 95% CI, 0.60 to 0.90; P=0.003). https://t.co/N0t6MqBECL
@medicalaxioms It would be great to look at the SPRINT blood pressure trial https://t.co/IKTETGlyfq
@Nicolas_C4 @JosephUdeSax @FC_actu https://t.co/CISMsqplDx
Some people have very politely (Some not so politely) requested the citations for the video above. For the courteous & curious - happy to share: 1. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 Nov 26;373(22):2103-16. 2. Assessment
RT @ISNkidneycare: SPRINT study included 40% elderly CKD patients, who had benefitted from strict control of BP? ➡️ More on "A Randomized T…
RT @ISNkidneycare: SPRINT study included 40% elderly CKD patients, who had benefitted from strict control of BP? ➡️ More on "A Randomized T…
RT @ISNkidneycare: SPRINT study included 40% elderly CKD patients, who had benefitted from strict control of BP? ➡️ More on "A Randomized T…
SPRINT study included 40% elderly CKD patients, who had benefitted from strict control of BP? ➡️ More on "A Randomized Trial of Intensive versus Standard Blood-Pressure Control" at @NEJM https://t.co/rYsiqZfj3K Join us: https://t.co/TOb7gmFwHj
@RichardLehman1 @raj_mehta @sfinnikin @stokemacca Likely every person has their own ideal BP based on their personal circumstances/comorbidities. I wrote a brief presentation on this here: https://t.co/byR6pa7J3o
Dr Attiaが血圧が高すぎないことが大事だと言っていたことを先日のFOREVER23でシェアしました。 たまたま「血圧は心配しなくていい」と言うある先生のビデオを見て下のリサーチ結果をシェアするべきだと思いました。NEJMに載った物でとても信頼度が高い物です。 https://t.co/zYkQomJOpK #ライブラン https://t.co/hOPqSbLYeV
@PeterDiamandis @elonmusk Evidence of SBP >120 is a cumulative slow poisoning effect of excess calories coupled with decreased physical activities ie after homo sapiens abandoned hunter gatherer lifestyle. Agriculture paved the way for mass production of carbs making most modern https://t.co/hDmMnQMFfG https://t.co/ROmsTtvCQA
RT @uppghnephrology: #VisualAbstract on target blood pressure control among #CKD patients. Learn on the SPRINT
#VisualAbstract on target blood pressure control among #CKD patients. Learn on the SPRINT
@ImgVasanth @spkalantri https://t.co/3bGF3HKpCw
RT @georgehret: #HYPHIP Q2: Can you remind us of the two treatment groups in #SPRINT https://t.co/gpMHVIYhxV and the main results please?…
RT @georgehret: #HYPHIP Q2: Can you remind us of the two treatment groups in #SPRINT https://t.co/gpMHVIYhxV and the main results please?…
RT @georgehret: #HYPHIP Q2: Can you remind us of the two treatment groups in #SPRINT https://t.co/gpMHVIYhxV and the main results please?…
RT @georgehret: #HYPHIP Q2: Can you remind us of the two treatment groups in #SPRINT https://t.co/gpMHVIYhxV and the main results please?…
#HYPHIP Q2: Can you remind us of the two treatment groups in #SPRINT https://t.co/gpMHVIYhxV and the main results please? @wccushman @HyperAHA
Referencias: - Jaeger, et al. (2022) JAMA cardiology, DOI: 10.1001/jamacardio.2022.3345 - SPRINT Research Group, (2015). NEJM 373(22), 2103–2116. DOI: 10.1056/NEJMoa1511939 #CardioEd #MedTwitter
The SPRINT blood pressure trial provides a great example of how community-based clinical trials can work. Their outreach to community sites allowed them to recruit 15,000 participants, more than their goal, and 50% of those patients were people of color. https://t.co/OfHyrvUKRA
Read the original study here: https://t.co/MBNKkUJtSI
RT @amjhypertension: Certain groups made that into a big deal, eg https://t.co/JPbCVtNgyp and https://t.co/4g8qT0weoP 3/ https://t.co/6zeX…
RT @amjhypertension: Why does this matter? Famously, in the SPRINT trial, BP was *planned* to be measured with the patient being alone http…
Certain groups made that into a big deal, eg https://t.co/JPbCVtNgyp and https://t.co/4g8qT0weoP 3/ https://t.co/6zeXoRD62A
Why does this matter? Famously, in the SPRINT trial, BP was *planned* to be measured with the patient being alone https://t.co/EQC6eL0o9D See #NephMadness coverage of this as well https://t.co/RQfPlb0alF 2/
RT @NephJC: T0c: In the
Available in: https://t.co/FJ4mJSenbt
I read this weekend a terrific article from @NEJM, “A Randomized Trial of Intensive versus Standard Blood-Pressure Control.” The conclusion was that an intensive blood pressure reduction decreased adverse cardiovascular outcomes compared with standard blood pressure treatment. https://t.co/lh0o1w1lMc
RT @gunnar_heine: Zielblutwerte bei Risikopatienten - STEP - Prof. Mann (München) https://t.co/ZyDjHkgqw0 via @YouTube jz online
Zielblutwerte bei Risikopatienten - STEP - Prof. Mann (München) https://t.co/ZyDjHkgqw0 via @YouTube jz online
RT @gunnar_heine: Zielblutwerte bei Risikopatienten - STEP - Prof. Mann (München) https://t.co/ZyDjHkgqw0 via @YouTube Morgen 12.11. 19:30!
Zielblutwerte bei Risikopatienten - STEP - Prof. Mann (München) https://t.co/ZyDjHkgqw0 via @YouTube Morgen 12.11. 19:30!
@EM_RESUS I’m sorry. Did you say chlorthalidone? https://t.co/NfaxZYDK1d #sprint @nih_nhlbi @NIDDKgov
@macesari Hard not to think about SPRINT as it was a game changer and went against a less is more mantra https://t.co/tdewU3tDXK
This trial was designed to understand the optimal BP targets to reduce CV mortality and morbidity (in those without diabetes)…https://t.co/LA1bb5vZAF
@nuri__karakaya @escardio Builds on the findings of the previous SPRINT trial https://t.co/IKTETGlyfq
9:08 T0c: In the
RT @NephJC: T0c: In the
RT @NephJC: T0c: In the
RT @NephJC: T0c: In the
RT @NephJC: T0c: In the
T0c: In the
Essas orientações são mais antigas do que o estudo SPRINT, referência para a AHA/ACC. A diretriz de 2017 aponta como ideal PA < 130 x 80 (não foram incluídos diabéticos). Esse alvo diminuiu desfechos cardiovasculares e morte, inclusive no grupo com DRC. https://t.co/xptUOBX1lM
En el estudio SPRINT se demostró beneficios en lograr metas más estrictas, con impacto en mortalidad, sin embargo el número de eventos no permite establecer diferencias en otros desenlaces individuales. https://t.co/YjjzdJLL6e
@BaeBielle Measuring improperly is always wrong, but they may be drawing from SPRINT’s writeup here. “Observational studies have shown a progressive increase in cardiovascular risk as systolic blood pressure rises above 115 mm Hg” https://t.co/mPTzFf0iaZ
@carlogubi Quasi nessun trial è open, per diversi motivi anche di privacy; forse l’unico è lo SPRINT (https://t.co/gwMHZp6082). Per questo esiste il sistema di peer review.
More intensive hypertension management helps more. https://t.co/8RtfgKwkD3
RT @HenryRunamucker: Claims of efficacy are extremely dubious. The trial ends with only 34 participants out of more than 100. Most well-con…
Claims of efficacy are extremely dubious. The trial ends with only 34 participants out of more than 100. Most well-conducted modern trials to determine efficacy of medical treatments have thousands of participants. See this trial, for example: https://t.co/5DFGr2jW5V
RT @RebeccaEBerger: @thebyrdlab Probably not what you are looking for, but in SPRINT, mean number of BP medications was 2.8 in intensive-tr…
@thebyrdlab Probably not what you are looking for, but in SPRINT, mean number of BP medications was 2.8 in intensive-treatment group and 1.8 in standard-treatment group https://t.co/sRjsu6fq9H
RT @jwilliamMD: #TullisFC this week! @marybethhamel, Exec Deputy Editor of @NEJM and @BIDMChealth PCP, will walk us through the criti…
@emmylou_breslin @clo13 @DrGerryG @CarryduffS @ursulaamason @Drbmcg @fillharmonica @davinacassidy @DrAndreaMurray @nigelhart @mcentee_siobhan @MARIAMONAGHAN9 @PeterBoylan2 @andre_harper @NiamhMcCormick9 @LINDAAGNEW12 @CSHenderson88 @monica_mckillen @WestBelfastGP @GpBelfast @gp_northern @EasternGp @GPTrainingNI @_NIMDTA @gpsouthbelfast @gpfed_derry Meant to include more on blood pressure targets both in general populations & with any signs of CKD. As a starter here’s a great video on the #SPRINT study’s main findings supporting lower targets. 2 minute view. https://t.co/mDoFnxVyE8
@KurtLass1 @holmanm Sprint trial showed mortality benefit treating to <120 sbp https://t.co/oUe1y3yeT2
Intensive blood pressure control (#SBP target of <120mmHg, compared with 140 mmHg) results in reduced incidence of fatal and non-fatal major adverse cardiovascular events and all-cause mortality. #SPRINT study. https://t.co/ieEfLy8FLZ
https://t.co/TITGQqhaQA @zaidkadwa @KursheedBadulla @RONALD41077142 @the_mc_muga @NelsonMweteri Intensive BP control w/ target 120/80mmHg reduced OR 0.75 all-cause mortality and CV related deaths
Interesting, those without #Diabetes should have lower #BP goals. #Hypertension. The #SPRINT trial.
Our first Journal Club of 2020 is today at noon! Drs. Hans Schwertz and Brent Shepherd will be presenting on jugular venous blood flow stasis and thrombosis during spaceflight and a randomized trial of intensive versus standard blood pressure control. https://t.co/OE4DoIdQb0
@MWFriedberg @rajesh_mohandas @boback @brzoskos Clinical trials are research experiments & will not look like today's practice in most instances No reason to suspect harm in the opinion of lots of hypertension experts not involved in the study Protocol available since time of publication https://t.co/RBkrWl8YR2
RT @jwilliamMD: #TullisFC this week! @marybethhamel, Exec Deputy Editor of @NEJM and @BIDMChealth PCP, will walk us through the criti…
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. https://t.co/G5iVHfncMy #jsphcs2019
Check out The SPRINT Research Group: A Randomized Trial of Intensive versus Standard Blood-Pressure Control https://t.co/em3MNKugrR
RT @carprimur: Desde hace unos años, @nejm nos brinda estos excepcionales vídeos resumen de los principales estudios. Aquí tenéis el del e…
C
FM
Z
NP
リ
KD
NP
SS